Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHIL
3001
DELISTED
Diamond Hill
DHIL
| $716K | ﹤0.01% |
3,686
+2,445
| +197% | +$489K |
|
3002
PUT
Aurinia Pharmaceuticals
AUPH
$1.91B
| $714K | ﹤0.01% |
+31,200
| New | +$739K |
|
3003
NexGen Energy
NXE
$6.06B
| $714K | ﹤0.01% |
163,200
-2,900
| -2% | -$14.9K |
|
3004
Vishay Precision Group
VPG
$1.22B
| $714K | ﹤0.01% |
19,246
+8,142
| +73% | +$291K |
|
|
CNSL
3005
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $712K | ﹤0.01% |
95,174
+36,854
| +63% | +$304K |
|
3006
Boston Omaha
BOC
$428M
| $710K | ﹤0.01% |
24,739
+17,526
| +243% | +$572K |
|
|
KZR
3007
DELISTED
Kezar Life Sciences
KZR
| $710K | ﹤0.01% |
4,246
+1,046
| +33% | +$118K |
|
3008
CALL
MGM Resorts International
MGM
$11.4B
| $709K | ﹤0.01% |
15,800
| – | – |
|
3009
Comscore
SCOR
$106M
| $709K | ﹤0.01% |
10,607
+2,819
| +36% | +$202K |
|
3010
W&T Offshore
WTI
$534M
| $709K | ﹤0.01% |
219,513
+50,562
| +30% | +$195K |
|
3011
Franklin Covey
FC
$242M
| $708K | ﹤0.01% |
15,286
+9,746
| +176% | +$432K |
|
3012
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $706K | ﹤0.01% |
2,770
-387
| -12% | -$97.5K |
|
3013
NRC Health Common Stock
NRC
$432M
| $704K | ﹤0.01% |
16,973
+7,447
| +78% | +$324K |
|
|
FLIC
3014
DELISTED
First of Long Island Corp
FLIC
| $703K | ﹤0.01% |
32,551
+18,333
| +129% | +$389K |
|
3015
RB Global
RBA
$20.4B
| $703K | ﹤0.01% |
11,484
-1,663
| -13% | -$111K |
|
3016
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $703K | ﹤0.01% |
4,900
| – | – |
|
|
TBRG
3017
DELISTED
TruBridge
TBRG
| $702K | ﹤0.01% |
24,000
+8,393
| +54% | +$274K |
|
3018
CALL
Ulta Beauty
ULTA
$22B
| $701K | ﹤0.01% |
1,700
| – | – |
|
3019
Teck Resources
TECK
$29.6B
| $700K | ﹤0.01% |
24,259
-68,701
| -74% | -$1.88M |
|
3020
CALL
Signet Jewelers
SIG
$3.61B
| $696K | ﹤0.01% |
8,000
| – | – |
|
|
BRY
3021
DELISTED
Berry Corp
BRY
| $690K | ﹤0.01% |
81,860
+50,986
| +165% | +$450K |
|
|
OLP
3022
One Liberty Properties
OLP
$530M
| $690K | ﹤0.01% |
19,556
+9,130
| +88% | +$302K |
|
|
ACBI
3023
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $688K | ﹤0.01% |
23,888
-27,431
| -53% | -$775K |
|
3024
EverQuote
EVER
$892M
| $686K | ﹤0.01% |
43,810
+12,569
| +40% | +$192K |
|
|
ICPT
3025
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $686K | ﹤0.01% |
42,079
+22,110
| +111% | +$373K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.